![Rational Combination of a MEK Inhibitor, Selumetinib, and the Wnt/Calcium Pathway Modulator, Cyclosporin A, in Preclinical Models of Colorectal Cancer]()
Rational Combination of a MEK Inhibitor, Selumetinib, and the Wnt/Calcium Pathway Modulator, Cyclosporin A, in Preclinical Models of Colorectal CancerSpreafico, A.; Tentler, J. J.; Pitts, T. M.; Tan, A. C.; Gregory, M. A.; Arcaroli, J. J.; Klauck, P. J.; McManus, M. C.; Hansen, R. J.; Kim, J.; Micel, L. N.; Selby, H. M.; Newton, T. P.; McPhillips, K. L.; Gustafson, D. L.; DeGregori, J. V.; Messersmith, W. A.; Winn, R. A.; Eckhardt, S. G. · Clinical Cancer Research · 2013